.svg){kind=small}
10 for the price of 1We have the capacity to replace multiple sites confirmed by our rapid and on-time recruitment.The power of foresightOur recruitment database of over 200,000 healthy and patient trial seekers provides in depth insight into study feasibility for streamlined study designs, saving both time and cost.
-min.jpg)
.jpg)
Latest news
Single-dose gene silencing cure for fatal heart disease comes one step closer
March 20, 2024
Richmond is delighted to be part of the first large-scale in-human trial of a genetic cure for ATTR Amyloidosis
Read moreHow Does Social Time Contribute to a Positive Workplace Culture?
March 13, 2023
Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.
Read moreEvents
ISA Symposium 2024
29-30 May 2024
We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota
View event
